Trividia Health
Private Company
Funding information not available
Overview
Trividia Health is a well-established, privately-held US company operating in the diabetes diagnostics and digital health sectors. Founded in 1985, it has a long history in the glucose monitoring market, primarily through its TRUE brand of blood glucose meters, test strips, and lancing devices. The company's strategy centers on providing reliable, cost-effective self-monitoring solutions directly to consumers through major retail channels, supplemented by patient education initiatives. Its position is that of a mature, commercial-stage player in the competitive diabetes care market.
Technology Platform
Electrochemical blood glucose monitoring systems (TRUE brand), with an indicated focus on digital health integration for data management and patient education.
Opportunities
Risk Factors
Competitive Landscape
Trividia competes in the crowded blood glucose monitoring market against giants like Roche (Accu-Chek), Abbott (FreeStyle), LifeScan (OneTouch), and Ascensia (Contour). Its primary competitive positioning is on value, affordability, and retail accessibility. The broader competitive threat comes from CGM leaders like Dexcom and Abbott, who are shifting the standard of care away from fingerstick testing.